Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346411 · ClinicalTrials.gov registry record
Health Outcomes in Rheumatoid Arthritis
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 164
- Enrollment target
NCT00346411: Completed study, sponsored by Johns Hopkins University.
NCT00346411 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00346411 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2005-09-01 |
| Est. Completion | 2011-12-12 |
What the finished NCT00346411 record still lists
NCT00346411 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00346411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00346411 about?
NCT00346411 is a clinical study titled "Health Outcomes in Rheumatoid Arthritis". This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may jo...
What is the current status of trial NCT00346411?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2005-09-01. Estimated completion is 2011-12-12.
Who is sponsoring clinical trial NCT00346411?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI